<DOC>
	<DOCNO>NCT01779635</DOCNO>
	<brief_summary>The investigator hypothesize use heparin-grafted membrane versus conventional membrane critically-ill patient bleeding-risk undergoing continuous renal replacement therapy , effectively prolong circuit lifespan , without worsen systemic APTT underlie bleed risk .</brief_summary>
	<brief_title>Efficacy Safety Heparin-grafted Membrane CRRT</brief_title>
	<detailed_description>Aims objective : We aim compare performance safety heparin-grafted AN69 membrane ( oXiris , Gambro ) conventional AN69 membrane ( M150 , Gambro ) without systemic anticoagulation continuous renal replacement therapy ( CRRT ) , critically ill patient acute kidney injury ( AKI ) admit intensive care unit ( ICU ) , moderate bleeding risk systemic anticoagulation contraindicate .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Adult patient ( age 21 ) admit ICUs CCU require CRRT acute kidney injury ESRD Patients moderate bleeding risk ( see definition ) Patients NO systemic regional circuit anticoagulation Informed consent take patient , proxy former unable sign due medical reason Anticipated need prolong CRRT &gt; 3 day ( Moderate bleeding risk criterion : ) Moderate bleeding risk define follow : 1 . Platelet count &lt; 100 x 109 mm3 ( &gt; 50 ) 2 . INR &gt; 1.5 ( &lt; 2.5 ) 3 . APTT &gt; 50 second ( &lt; 75 ) 4 . Postsurgery &lt; 48 hour 5 . Postinvasive procedure ( eg . Pericardiocentasis ) &lt; 24 hr 6 . Post major artery puncture catheter removal major artery ( carotids , subclavian , femoral ) &lt; 24 hour 7 . Recent internal gastrointestinal bleeding within 48 hour ( secure bleeding relapse note ) Patients high bleeding risk ( also fall outside inclusion criterion see ) Patients know heparininduced thrombocytopenia allergic heparin Patients medical condition heparin contraindicate . Patients require systemic anticoagulation medical indication ( We accept patient prophylactic dos anticoagulation DVT prophylaxis ) Patients pregnant Patients/legally accept surrogate decline consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Heparin-grafted membrane</keyword>
	<keyword>Circuit lifespan</keyword>
	<keyword>Continuous renal replacement therapy</keyword>
	<keyword>Anticoagulation free</keyword>
	<keyword>Bleeding risk</keyword>
	<keyword>Acute kidney injury</keyword>
	<keyword>Critical illness</keyword>
</DOC>